S. Harding

发表

A comparison of oral and inhaled steroids in patients with chronic airways obstruction: features determining response.

S. Freedman, S. Harding, 1978, Thorax.

The clinical pharmacology of ondansetron.

S. Harding, C. P. Blackwell, 1989, European journal of cancer & clinical oncology.

A dose-ranging study of fluticasone propionate administered once daily via multidose powder inhaler to patients with moderate asthma.

R. Nathan, S. Harding, J. T. Li, 2000, Chest.

Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma.

D. Kellerman, K. Faulkner, L. Ford, 1999, The Journal of allergy and clinical immunology.

Simultaneous comparison of three methods for assessing ceftazidime penetration into extravascular fluid

D. M. Ryan, S. Harding, B. Hodges, 1982, Antimicrobial Agents and Chemotherapy.

The dull-edged sword of inhaled corticosteroids.

S. Harding, 1999, Chest.

Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic-acid-induced platelet dysfunction.

D. Drotar, R. Card, S. Harding, 1994, Canadian journal of surgery. Journal canadien de chirurgie.

Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma.

W. Silvers, S. Duke, C. Laforce, 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Potential effects of fluticasone propionate on bone mineral density in patients with asthma: a 2-year randomized, double-blind, placebo-controlled trial.

J. Kemp, C. Crim, K. Faulkner, 2004, Mayo Clinic proceedings.

Clinical Pharmacology of Lacidipine

S. Harding, M. Pellegatti, G. Evans, 1991, Journal of cardiovascular pharmacology.

Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.

S. Harding, G. Gross, S. Galant, 1999, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Pharmacokinetics of Fluticasone Propionate Inhaled via the Diskhaler® and Diskus® Powder Devices in Patients with Mild-to-Moderate Asthma

P. Daley-Yates, J. Horton, S. Harding, 2000, Clinical pharmacokinetics.

GERD, AIRWAY DISEASE, AND THE MECHANISMS OF INTERACTION

S. Harding, 1999 .

Chapter 14 – Corticosteroids

S. Harding, 1984 .

The penetration of ceftazidime into extravascular fluid.

D. M. Ryan, S. Harding, U. Mason, 1981, The Journal of antimicrobial chemotherapy.

Pharmacokinetics of ceftazidime in male and female volunteers

J. Ayrton, D. Sommers, S. Harding, 1983, Antimicrobial Agents and Chemotherapy.

GR 20263, a new broad-spectrum cephalosporin with anti-pseudomonal activity

D. M. Ryan, C. O'callaghan, S. Kirby, 1980, Antimicrobial Agents and Chemotherapy.

The comparative pharmacokinetics of ceftazidime and cefotaxime in healthy volunteers.

J. Ayrton, S. Harding, M. Hogg, 1981, The Journal of antimicrobial chemotherapy.

Pharmacokinetics of ceftazidime in normal subjects.

A. Munro, J. Ayrton, S. Harding, 1981, The Journal of antimicrobial chemotherapy.

The human pharmacology of fluticasone propionate.

S. Harding, 1990, Respiratory medicine.

Intranasal betamethasone valerate in the treatment of seasonal rhinitis

S. Harding, S. Harding, A. K. Thomas, 1975, Clinical allergy.

The absolute bioavailability of oral cefuroxime axetil in male and female volunteers after fasting and after food.

P. Williams, S. Harding, 1984, The Journal of antimicrobial chemotherapy.

Pharmacology of Cefuroxime as the 1-acetoxyethyl ester in volunteers

J. Ayrton, P. Williams, S. Harding, 1984, Antimicrobial Agents and Chemotherapy.

Comparison of the bioavailabilities and anticoagulant activities of two warfarin formulations

C. Towler, R. Bland, Y. Stirling, 1982, British journal of haematology.

Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma.

R. Zuwallack, S. Duke, S. Harding, 2000, Chest.

Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by diskus device in patients with asthma treated with or without inhaled corticosteroids.

A. Rooklin, S. Duke, S. Harding, 2000, The Journal of allergy and clinical immunology.

Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma.

W. Busse, D. Webb, H. Nelson, 1999, The Journal of allergy and clinical immunology.

Pharmacokinetics and tolerance of cefuroxime axetil in volunteers during repeated dosing

P. Williams, D. Sommers, S. Harding, 1984, Antimicrobial Agents and Chemotherapy.

Bioequivalency of Two Brands of Cephalothin Sodium

P. Williams, S. Harding, H. Bhattacharyya, 1985 .

Pharmacokinetics of the third-generation cephalosporins.

S. Harding, 1985, The American journal of medicine.

Betamethasone valerate aerosol in the treatment of oral lichen planus

S. Harding, W. Tyldesley, 1977, The British journal of dermatology.

Factors affecting the intramuscular absorption of cefuroxime.

A. Harris, S. Harding, L. Eilon, 1979, The Journal of antimicrobial chemotherapy.

The pharmacokinetic behaviour of ceftazidime in man and the relationship between serum levels and the in vitro susceptibility of clinical isolates

S. Harding, P. B. Harper, 2005, Infection.

Percutaneous absorption of clobetasol propionate from novel ointment and cream formulations

S. Harding, S. Harding, S. Sohail, 1985, Clinical and experimental dermatology.

The Pharmacokinetics of Cefuroxime in Man in Relation to its Antibacterial Activity

C. O'callaghan, S. Harding, 1977 .

Intranasal steroid aerosol in perennial rhinitis: comparison with an antihistamine compound

S. Heath, S. Harding, S. Harding, 1976, Clinical allergy.